Vinorelbine and Docetaxel Combination as the First Line Treatment in Patients with Metastatic Breast Cancer: Results of a Multi-centric Phase II Trial in Iran

AuthorAhamad Amerien
AuthorBehrouz Shahraden
AuthorAbollah Fazlalizadehen
AuthorHossein Madanien
AuthorAhmad Mousavizadehen
AuthorShiva Moghadamen
Issued Date2013-09-01en
AbstractIntroduction: We conducted a multi-centric phase II study to evaluate the tumor response and safety of the combination of vinorelbin and docetaxel in treatment of metastatic breast cancer patients.en
DOIhttps://doi.org/en
KeywordMetastatic breast canceren
Keywordchemotherapyen
Keywordvinorelbineen
Keyworddocetaxelen
PublisherBrieflandsen
TitleVinorelbine and Docetaxel Combination as the First Line Treatment in Patients with Metastatic Breast Cancer: Results of a Multi-centric Phase II Trial in Iranen
TypeResearch Articleen

Files